• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与帕金森病相关的 GBA1 c.231C > G 突变导致功能丧失。

The loss of function GBA1 c.231C > G mutation associated with Parkinson disease.

机构信息

Department of Neurology, Yunfu People's Hospital, Yunfu, China.

Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

出版信息

J Neural Transm (Vienna). 2023 Jul;130(7):905-913. doi: 10.1007/s00702-023-02651-4. Epub 2023 Jun 6.

DOI:10.1007/s00702-023-02651-4
PMID:37280314
Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease characterized by bradykinesia, rigidity, and tremor. However, familial PD caused by single-gene mutations remain relatively rare. Herein, we described a Chinese family affected by PD, which associated with a missense heterozygous glucocerebrosidase 1 (GBA1) mutation (c.231C > G). Clinical data on the proband and her family members were collected. Brain MRI showed no difference between affected and unaffected family members. Whole-exome sequencing (WES) was performed to identify the pathogenic mutation. WES revealed that the proband carried a missense mutation (c.231C > G) in GBA1 gene, which was considered to be associated with PD in this family. Sanger sequencing and co-segregation analyses were used to validate the mutation. Bioinformatics analysis indicated that the mutation was predicted to be damaging. In vitro functional analyses were performed to investigated the mutant gene. A decrease in mRNA and protein expression was observed in HEK293T cells transfected with mutant plasmids. The GBA1 c.231C > G mutation caused a decreased GBA1 concentration and enzyme activity. In conclusion, a loss of function mutation (c.231C > G) in GBA1 was identified in a Chinese PD family and was confirmed to be pathogenic through functional studies. This study help the family members understand the disease progression and provide a new example for studying the pathogenesis of GBA1-associated Parkinson disease.

摘要

帕金森病(PD)是第二常见的神经退行性疾病,其特征为运动迟缓、僵直和震颤。然而,由单基因突变引起的家族性 PD 仍然相对罕见。在此,我们描述了一个受 PD 影响的中国家族,该家族与葡萄糖脑苷脂酶 1(GBA1)基因突变(c.231C>G)杂合有关。收集了先证者及其家族成员的临床数据。脑 MRI 显示受影响和未受影响的家族成员之间没有差异。进行全外显子组测序(WES)以鉴定致病突变。WES 显示先证者携带 GBA1 基因中的错义突变(c.231C>G),该突变被认为与该家族的 PD 相关。Sanger 测序和共分离分析用于验证突变。生物信息学分析表明该突变被预测为有害。进行体外功能分析以研究突变基因。转染突变质粒的 HEK293T 细胞中观察到 mRNA 和蛋白质表达减少。GBA1 c.231C>G 突变导致 GBA1 浓度和酶活性降低。总之,在中国 PD 家族中鉴定出 GBA1 中的功能丧失突变(c.231C>G),并通过功能研究证实其具有致病性。该研究有助于家族成员了解疾病进展,并为研究 GBA1 相关帕金森病的发病机制提供了新的范例。

相似文献

1
The loss of function GBA1 c.231C > G mutation associated with Parkinson disease.与帕金森病相关的 GBA1 c.231C > G 突变导致功能丧失。
J Neural Transm (Vienna). 2023 Jul;130(7):905-913. doi: 10.1007/s00702-023-02651-4. Epub 2023 Jun 6.
2
-Associated Parkinson's Disease Is a Distinct Entity.与帕金森病相关联的疾病是一个独特的实体。
Int J Mol Sci. 2024 Jun 28;25(13):7102. doi: 10.3390/ijms25137102.
3
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues.靶向 GBA1 通路以减缓帕金森病:临床方面、发病机制和新治疗途径的见解。
Pharmacol Ther. 2023 Jun;246:108419. doi: 10.1016/j.pharmthera.2023.108419. Epub 2023 Apr 19.
4
Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation.帕金森病相关 GBA1 突变的干细胞衍生神经元模型中葡萄糖脑苷脂酶活性、组织蛋白酶 D 和单体α-突触核蛋白相互作用。
Neurobiol Dis. 2020 Feb;134:104620. doi: 10.1016/j.nbd.2019.104620. Epub 2019 Oct 18.
5
Ambroxol reverses tau and α-synuclein accumulation in a cholinergic N370S GBA1 mutation model.安溴索逆转了胆碱能 N370S GBA1 突变模型中的 tau 和 α-突触核蛋白积累。
Hum Mol Genet. 2022 Jul 21;31(14):2396-2405. doi: 10.1093/hmg/ddac038.
6
The relationship between glucocerebrosidase mutations and Parkinson disease.葡萄糖脑苷脂酶突变与帕金森病之间的关系。
J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10.
7
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.安布罗醇诱导缺陷型葡萄糖脑苷脂酶的恢复与 GBA1 突变型帕金森病细胞中 LIMP-2 和神经鞘脂激活蛋白 C 水平的升高有关。
Neurobiol Dis. 2015 Oct;82:235-242. doi: 10.1016/j.nbd.2015.06.008. Epub 2015 Jun 19.
8
Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.酸性鞘磷脂酶参与导致 GBA1 相关帕金森病 iPSC 模型中α-突触核蛋白积累的致病级联反应。
Hum Mol Genet. 2023 May 18;32(11):1888-1900. doi: 10.1093/hmg/ddad025.
9
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.GBA突变型帕金森病中的葡萄糖脑苷脂酶活性
J Clin Neurosci. 2016 Jun;28:185-6. doi: 10.1016/j.jocn.2015.12.004. Epub 2016 Feb 5.
10
The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson's Disease: a New Genetic State of the Art.β-葡糖苷酶(Gba1)在帕金森病中的分子影响:一个新的遗传学研究现状。
Mol Neurobiol. 2024 Sep;61(9):6754-6770. doi: 10.1007/s12035-024-04008-8. Epub 2024 Feb 13.

本文引用的文献

1
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.基因组测序分析鉴定出与路易体痴呆相关的新基因座,并深入了解其遗传结构。
Nat Genet. 2021 Mar;53(3):294-303. doi: 10.1038/s41588-021-00785-3. Epub 2021 Feb 15.
2
Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.帕金森病中葡萄糖脑苷脂酶(GBA)突变的外显率:一项近亲队列研究。
Mov Disord. 2020 Nov;35(11):2111-2114. doi: 10.1002/mds.28200. Epub 2020 Aug 7.
3
Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients With Early-Onset Parkinson's Disease.
评估SNCA、LRRK2和GBA在中国早发性帕金森病患者中的作用。
Mov Disord. 2020 Nov;35(11):2046-2055. doi: 10.1002/mds.28191. Epub 2020 Jul 16.
4
Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.葡萄糖脑苷脂酶缺乏促进培养神经元中α-突触核蛋白原纤维的释放。
Hum Mol Genet. 2020 Jun 27;29(10):1716-1728. doi: 10.1093/hmg/ddaa085.
5
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease.葡萄糖脑苷脂酶缺陷是帕金森病的主要危险因素。
Front Aging Neurosci. 2020 Apr 21;12:97. doi: 10.3389/fnagi.2020.00097. eCollection 2020.
6
Endosomal sorting pathways in the pathogenesis of Parkinson's disease.帕金森病发病机制中的内体分选途径。
Prog Brain Res. 2020;252:271-306. doi: 10.1016/bs.pbr.2020.02.001. Epub 2020 Mar 16.
7
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.GBA 相关帕金森病和路易体痴呆风险和发病年龄的遗传修饰物。
Brain. 2020 Jan 1;143(1):234-248. doi: 10.1093/brain/awz350.
8
Evolution of prodromal parkinsonian features in a cohort of mutation-positive individuals: a 6-year longitudinal study.队列研究中突变阳性个体前驱帕金森特征的演变:一项 6 年纵向研究。
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1091-1097. doi: 10.1136/jnnp-2019-320394. Epub 2019 Jun 20.
9
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
10
Clinical and molecular characteristics of patients with Gaucher disease in Southern China.中国南方戈谢病患者的临床和分子特征
Blood Cells Mol Dis. 2018 Feb;68:30-34. doi: 10.1016/j.bcmd.2016.10.026. Epub 2016 Nov 3.